Christina Marie Wyatt, MD

Associate Professor of Medicine
Member of the Duke Clinical Research Institute
Email address christina.wyatt@duke.edu

Education and Training

  • Chief Resident, Medicine, Icahn School of Medicine at Mount Sinai, 2004 - 2005
  • Nephrology Fellowship, Icahn School of Medicine at Mount Sinai, 2002 - 2004
  • Internal Medicine Residency, Medicine, Icahn School of Medicine at Mount Sinai, 1999 - 2002
  • M.D., Duke University School of Medicine, 1999

Publications

Sawinski, Deirdre, Kimberly A. Forde, and Christina M. Wyatt. “New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat..” Am J Kidney Dis 72, no. 1 (July 2018): 7–9. https://doi.org/10.1053/j.ajkd.2018.01.049.

PMID
29580661
Full Text

Wyatt, Christina M., and T Alp Ikizler. “Isotonic fluids for volume resuscitation: is it really 6 liters of one, half a dozen of another?.” Kidney Int 93, no. 6 (June 2018): 1262–64. https://doi.org/10.1016/j.kint.2018.04.003.

PMID
29792267
Full Text

Wyatt, Christina M., and Nicola Wanner. “Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults..” Kidney Int 93, no. 6 (June 2018): 1260–62. https://doi.org/10.1016/j.kint.2018.04.009.

PMID
29792266
Full Text

Wyatt, Christina M., and Glenn M. Chertow. “Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology..” Kidney Int 93, no. 4 (April 2018): 768–70. https://doi.org/10.1016/j.kint.2018.01.017.

PMID
29475561
Full Text

Justice, Amy C., Kirsha S. Gordon, Melissa Skanderson, Eva Jennifer Edelman, Kathleen M. Akgün, Cynthia L. Gibert, Vincent Lo Re, et al. “Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals..” Aids 32, no. 6 (March 27, 2018): 739–49. https://doi.org/10.1097/QAD.0000000000001756.

PMID
29543653
Full Text

Wyatt, Christina M., and Steven D. Crowley. “Intersection of salt- and immune-mediated mechanisms of hypertension in the gut microbiome..” Kidney Int 93, no. 3 (March 2018): 532–34. https://doi.org/10.1016/j.kint.2018.01.001.

PMID
29475542
Full Text

Swanepoel, Charles R., Mohamed G. Atta, Vivette D. D’Agati, Michelle M. Estrella, Agnes B. Fogo, Saraladevi Naicker, Frank A. Post, et al. “Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference..” In Kidney Int, 93:545–59, 2018. https://doi.org/10.1016/j.kint.2017.11.007.

PMID
29398134
Full Text

Chan, Lili, Benjamin Asriel, Ellen F. Eaton, and Christina M. Wyatt. “Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug..” Curr Opin Nephrol Hypertens 27, no. 2 (March 2018): 102–12. https://doi.org/10.1097/MNH.0000000000000392.

PMID
29278542
Full Text

Pages